Alpha Healthcare Acquisition Corp. III
closedU=S+W/4W=S@11.50
ALPA
Capital Structure & Economics
Trust Size$150,000,000
Unit Price$2.25
Warrant Coverage1/4
Sponsor Promote20%
Implied Equity Architecture
Capital Allocation Baseline
Trust (100.0%)
Implied Dilution Drag
25% Warrant Inclusion| Public Trust Allocation | $150,000,000 |
| Sponsor At-Risk Capital | N/A |
| Total Underwriting Discount | N/A |
| Trust Per Unit (Implied) | $2.25 |
| Sponsor Promote Allocation | 20% |
Deal Lifecycle
IPO PricedMar 4, 2021
SearchingTarget Pending
Maturation Wall
N/A
Announced Target / M&A
- Target CompanyCarmell Therapeutics Corporation
- SectorBiotechnology
- Announced Deal Size$150,000,000
Board & Officers
- CEO
- Director
- Rich UptonDirector
- Kathryn GregoryDirector
- Scott FrischDirector
- Gilles SpenlehauerDirector
- Patrick SturgeonDirector
- William NewlinDirector
- Steve BariahtarisDirector
- Jaime GarzaDirector
- Director
- Jaime Garza, MDDirector
- Darlene T. DeRemerDirector
- Eugene L. PodsiadloDirector
- Director
Advanced Structuring Terms
| Target Sectors | Biotechnology |
Syndicate & Advisors
Interactive Deal Modeling
Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.